Im
Immunomedics (Gilead)
Morris Plains NJFounded 19831,200 employees
Private CapbiotechAcquiredOncology
Platform: Trodelvy ADC
Market Cap
N/A
All Drugs
4
Clinical Trials
9
Failed / Terminated
1
FDA Approved
1
Drug Pipeline (4 programs)
| Drug Name | Code | Phase | Trials | Modality | Target | MOA | Indications |
|---|---|---|---|---|---|---|---|
| Suraosocimab | IMM-5097 | Phase 1/2 | 2 | FLT3 | DravetCeliac | ||
| Voxavorutinib | IMM-9672 | Phase 3 | 1 | CD123 | MCL | ||
| IMM-2816 | IMM-2816 | Approved | 4 | Cl18.2 | LGSADPKD | ||
| IMM-5415 | IMM-5415 | Preclinical | 2 | PD-1 | Parkinson'sWet AMD |
Financial Documents
This company has been acquired — see parent company for financial filings.
Catalyst Events (9)